Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

FHS
July 11, 2024
12:31 pm

A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.

Meet the billionaire media mogul who’s taking on the food industry

WASHINGTON — The idea for Todd Wagner’s new advocacy organization FoodFight USA, he says, came to him after visiting George Clooney in Lake Como. He’s

August 13, 2024

More Data Support Adding Immunotherapy to Chemo in Advanced Endometrial Cancer

MADRID — Patients with advanced endometrial cancer had less disease progression and lived longer when they received the immune checkpoint inhibitor (ICI) atezolizumab (Tecentriq) in

October 24, 2023

Lilly’s weekly insulin hits primary endpoints in two more late-stage diabetes studies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.